Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b

Figure 4 Longitudinal changes in serum total cholesterol and low-density lipoprotein cholesterol during and after the treatment in DCV + ASV-nSVR group. Mean value of serum TC and LDL-C at baseline (0W), 4 wk (4W), 8 wk (8W), 12 wk (12W), and 24 wk (24W) of DCV + ASV treatment and 4 wk (P4W) and 12 wk (P12W) after the end of DCV + ASV treatment was plotted. Vertical line expressed the range of mean ± SD. Statistical significance from baseline was indicated at upper part of each graph (^aP < 0.05). DCV: Daclatasvir; ASV: Asunaprevir; TC: Total cholesterol; LDL-C: Low-density lipoprotein cholesterol.